RGEN(Repligen Corporation) · 财务报表

RGEN(Repligen Corporation) 的财务报表:医疗保健,医疗仪器与耗材。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$670.53M$801.54M$632.36M$634.44M$738.26M
毛利润$391.25M$455.71M$278.44M$274.64M$386.25M
营业利润$167.25M$224.67M$47.70M−$35.11M$55.17M
净利润$128.29M$185.96M$35.60M−$25.51M$48.89M
经营现金流$119.02M$172.08M$113.92M$175.39M$117.42M
自由现金流$51.93M$87.25M$77.70M$149.72M$93.90M
摊薄每股收益$2.24$3.24$0.63$-0.46$0.86

Repligen Corporation RGEN